The DOI matches its Crossref record; 421 of the 427 references it cites were found in a registry or an index.
Cost of disorders of the brain in Europe 2010
Open accessAbstract
Background The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people.Aims To estimate the number of persons with defined disorders of the brain in Europe in 2010, the total cost per person related to each disease in terms of direct and indirect costs, and an estimate of the total cost per disorder and country.Methods The best available estimates of the prevalence and cost per person for 19 groups of disorders of the brain (covering well over 100 specific disorders) were identified via a systematic review of the published literature. Together with the twelve disorders included in 2004, the following range of mental and neurologic groups of disorders is covered: addictive disorders, affective disorders, anxiety disorders, brain tumor, childhood and adolescent disorders (developmental disorders), dementia, eating disorders, epilepsy, mental retardation, migraine, multiple sclerosis, neuromuscular disorders, Parkinson's disease, personality disorders, psychotic disorders, sleep disorders, somatoform disorders, stroke, and traumatic brain injury. Epidemiologic panels were charged to complete the literature review for each disorder in order to estimate the 12-month prevalence, and health economic panels were charged to estimate best cost-estimates. A cost model was developed to combine the epidemiologic and economic data and estimate the total cost of each disorder in each of 30 European countries (EU27+Iceland, Norway and Switzerland). The cost model was populated with national statistics from Eurostat to adjust all costs to 2010 values, converting all local currencies to Euro, imputing costs for countries where no data were available, and aggregating country estimates to purchasing power parity adjusted estimates for the total cost of disorders of the brain in Europe 2010.Results The total cost of disorders of the brain was estimated at €798 billion in 2010. Direct costs constitute the majority of costs (37% direct healthcare costs and 23% direct non-medical costs) whereas the remaining 40% were indirect costs associated with patients' production losses. On average, the estimated cost per person with a disorder of the brain in Europe ranged between €285 for headache and €30,000 for neuromuscular disorders. The European per capita cost of disorders of the brain was €1550 on average but varied by country. The cost (in billion €PPP 2010) of the disorders of the brain included in this study was as follows: addiction: €65.7; anxiety disorders: €74.4; brain tumor: €5.2; child/adolescent disorders: €21.3; dementia: €105.2; eating disorders: €0.8; epilepsy: €13.8; headache: €43.5; mental retardation: €43.3; mood disorders: €113.4; multiple sclerosis: €14.6; neuromuscular disorders: €7.7; Parkinson's disease: €13.9; personality disorders: €27.3; psychotic disorders: €93.9; sleep disorders: €35.4; somatoform disorder: €21.2; stroke: €64.1; traumatic brain injury: €33.0. It should be noted that the revised estimate of those disorders included in the previous 2004 report constituted €477 billion, by and large confirming our previous study results after considering the inflation and population increase since 2004. Further, our results were consistent with administrative data on the health care expenditure in Europe, and comparable to previous studies on the cost of specific disorders in Europe. Our estimates were lower than comparable estimates from the US.Discussion This study was based on the best currently available data in Europe and our model enabled extrapolation to countries where no data could be found. Still, the scarcity of data is an important source of uncertainty in our estimates and may imply over- or underestimations in some disorders and countries. Even though this review included many disorders, diagnoses, age groups and cost items that were omitted in 2004, there are still remaining disorders that could not be included due to limitations in the available data. We therefore consider our estimate of the total cost of the disorders of the brain in Europe to be conservative. In terms of the health economic burden outlined in this report, disorders of the brain likely constitute the number one economic challenge for European health care, now and in the future. Data presented in this report should be considered by all stakeholder groups, including policy makers, industry and patient advocacy groups, to reconsider the current science, research and public health agenda and define a coordinated plan of action of various levels to address the associated challenges.Recommendations Political action is required in light of the present high cost of disorders of the brain. Funding of brain research must be increased; care for patients with brain disorders as well as teaching at medical schools and other health related educations must be quantitatively and qualitatively improved, including psychological treatments. The current move of the pharmaceutical industry away from brain related indications must be halted and reversed. Continued research into the cost of the many disorders not included in the present study is warranted. It is essential that not only the EU but also the national governments forcefully support these initiatives.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The economic costs of headaches are substantial, primarily manifesting as indirect and intangible costs. This includes work absences because of headaches (absenteeism), reduced on-the-job performance while experiencing headaches (presenteeism), reduced quality of life, and increased pain outside the workplace [5-7].”
In the citing paper
“Persistent depressive disorder (PDD) is characterized by psychosocial impairment (Angst et al. 2009; Gustavsson et al. 2011; Klein et al. 1988), high comorbidity (Köhler et al. 2019), low rates of spontaneous remission (McCullough et al. 1988) and poorer treatment outcomes compared to episodic depression (Stewart et al. 1989; Thase et al. 1994).”
From Reciprocal Dynamics of Therapeutic Alliance and Depressive Symptoms in Inpatient Cognitive Behavioural Analysis System of Psychotherapy: The Role of Attachment Insecurity. (2025) · cites this paper as Gustavsson et al. 2011
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183
Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective
Young, T., Peppard, P. E., & Gottlieb, D. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109080 · Cited by 4,244
Estimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,032
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,825
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Self-citationOosterhuis, H. (1997) · Cited by 2,397
Estimates of cancer incidence and mortality in Europe in 2008
Ferlay, J., Parkin, D. M., & Steliarova‐Foucher, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.014 · Cited by 2,323
Epidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971
Research works printed but not linked: 8
- Atance Martinez, 2004, Costs study in Alzheimer's disease, Rev. Clin. Esp., 204, 64
- Bertelli, 2009, New contributions of psychiatric research in the field of intellectual disabilities, Adv. Psychiatry, 3, 37
- Cavallo, 1997, The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy, Alzheimer Dis. Assoc. Disord., 11, 184
- Gessner, 1993, The cost of epilepsy in Switzerland, Int. J. Health Sci., 4, 121
- Mahdi-Rogers, 2008, Epidemiology and treatment of chronic inflammatory neuropathies in South East England, Eur. J. Neurol., 15
- Salize, 2004, Cost of care for depressive disorders in primary and specialized care in Germany, Psychiatr. Prax., 31, 147
- Wilms, 2004, Illness related costs for spouses of patients suffering from a mental illness: results of a study with repeated measurements, Psychiatr. Prax., 31, 177
- Wittchen, 2010, The timing of depression: an epidemiological perspective, Medicographia, 32, 155-125
Cited by
Sorted by citations
Items 101–200 of 1,008
Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Cameron, L. P., Benson, C. J., Dunlap, L. E., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00134 · Cited by 171
Nunes, A., Schnack, H. G., Ching, C. R. K., Agartz, I., Akudjedu, T. N., Alda, M., Alnæs, D., Alonso-Lana, S., Bauer, J., Baune, B. T., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0228-9 · Cited by 180
Pauley, D., Cuijpers, P., Papola, D., Miguel, C., & Karyotaki, E. (2021) · Psychological Medicine · doi:10.1017/s0033291721001999 · Cited by 170
Wobrock, T., Guse, B., Cordes, J., Wölwer, W., Winterer, G., Gäebel, W., Langguth, B., Landgrebe, M., Eichhammer, P., Frank, E., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.009 · Cited by 176
Psychotherapies for depression in low- and middle-income countries: a meta-analysis
Cuijpers, P., Karyotaki, E., Reijnders, M., Purgato, M., & Barbui, C. (2018) · World Psychiatry · doi:10.1002/wps.20493 · Cited by 159
Pittig, A., Kotter, R., & Hoyer, J. (2019) · Behavior Therapy · doi:10.1016/j.beth.2018.07.003 · Cited by 160
Bandelow, B., Baldwin, D. S., Abelli, M., Altamura, C. A., Dell’Osso, B. M., Domschke, K., Fineberg, N. A., Grünblatt, E., Jarema, M., Maron, E., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1181783 · Cited by 174
Advancing psychotherapy and evidence‐based psychological interventions
Emmelkamp, P. M. G., David, D., Beckers, T., Muris, P., Cuijpers, P. J., Lutz, W., Andersson, G., Araya, R., Rivera, R. M. B., Barkham, M., et al. (2013) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1411 · Cited by 184
Thelin, E. P., Jeppsson, E., Frostell, A., Svensson, M. A., Mondello, S., Bellander, B., & Nelson, D. (2016) · Critical Care · doi:10.1186/s13054-016-1450-y · Cited by 163
Self-citationTraumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus
Hazeldine, J., Lord, J. M., & Belli, A. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00235 · Cited by 163
The economic burden of mental disorders in China, 2005–2013: implications for health policy
Xu, J., Wang, J., Wimo, A. B., & Qiu, C. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0839-0 · Cited by 155
Phillips, C. M., Shivappa, N., Hébert, J. R., & Perry, I. J. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.08.029 · Cited by 160
Automatic detection of Parkinson’s disease based on acoustic analysis of speech
Braga, D., Madureira, A. M., Coelho, L. P., & Ajith, R. (2018) · Engineering Applications of Artificial Intelligence · doi:10.1016/j.engappai.2018.09.018 · Cited by 159
Pitkälä, K., Savikko, N., Poysti, M., Strandberg, T., & Laakkonen, M.-L. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2012.08.008 · Cited by 152
Berger, T., Krieger, T., Sude, K., Meyer, B., & Maercker, A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.021 · Cited by 153
Self-citationMurray, A., Toussaint, A. C., Althaus, A., & Löwe, B. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.11.002 · Cited by 154
Brain Age in Early Stages of Bipolar Disorders or Schizophrenia
Hájek, T., Franke, K., Kolenič, M., Capkova, J., Matějka, M., Propper, L., Uher, R., Stopková, P., Novák, T., Paus, T., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx172 · Cited by 153
The Role of Diet as a Modulator of the Inflammatory Process in the Neurological Diseases
Kurowska, A., Ziemichód, W., Herbet, M., & Piątkowska‐Chmiel, I. (2023) · Nutrients · doi:10.3390/nu15061436 · Cited by 168
Kleiboer, A., Smit, J., Bosmans, J., Ruwaard, J., Andersson, G., Topooco, N., Berger, T., Krieger, T., Botella, C., Baños, R., et al. (2016) · Trials · doi:10.1186/s13063-016-1511-1 · Cited by 133
Six Action Steps to Address Global Disparities in Parkinson Disease
Schiess, N., Cataldi, R., Okun, M. S., Fothergill‐Misbah, N., Dorsey, E. R., Bloem, B. R., Barretto, M., Bhidayasiri, R., Brown, R. J., Chishimba, L., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.1783 · Cited by 155
Steinert, C., Hofmann, M., Kruse, J., & Leichsenring, F. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.017 · Cited by 156
Charbogne, P., Kieffer, B. L., & Befort, K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.028 · Cited by 161
The role of neuroimaging in Parkinson’s disease
Bidesi, N., Andersen, I. V., Windhorst, A. D., Shalgunov, V., & Herth, M. M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15516 · Cited by 159
Virtual reality exposure in anxiety disorders: Impact on psychophysiological reactivity
Diemer, J., Mühlberger, A., Pauli, P., & Zwanzger, P. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.892632 · Cited by 146
Hickie, I. B., Naismith, S. L., Robillard, R., Scott, E. M., & Hermens, D. F. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-79 · Cited by 159
Early interventions in risk groups for schizophrenia: what are we waiting for?
Sommer, I. E., Bearden, C. E., van Dellen, E., Breetvelt, E. J., Duijff, S. N., Maijer, K., van Amelsvoort, T., de Haan, L., Gur, R. E., Arango, C., et al. (2016) · npj Schizophrenia · doi:10.1038/npjschz.2016.3 · Cited by 140
Drug delivery across the blood–brain barrier using focused ultrasound
Burgess, A., & Hynynen, K. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.897693 · Cited by 142
Depressive disorders: treatment failures and poor prognosis over the last 50 years
Blackburn, T. P. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.472 · Cited by 136
Robillard, R., Naismith, S. L., Rogers, N. L., Scott, E. M., Ip, T. K. C., Hermens, D. F., & Hickie, I. B. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.04.001 · Cited by 145
The Development, Past Achievements, and Future Directions of Brain PET
Jones, T., & Rabiner, E. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.20 · Cited by 145
DeBuc, D. C., Somfai, G. M., & Koller, Á. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00201.2016 · Cited by 149
Research priorities for public mental health in Europe: recommendations of the ROAMER project
Forsman, A. K., Wahlbeck, K., Aaro, L. E., Alonso, J., Barry, M. M., Brunn, M., Cardoso, G., Cattan, M., de Girolamo, G., Eberhard-Gran, M., et al. (2015) · The European Journal of Public Health · doi:10.1093/eurpub/cku232 · Cited by 139
Self-citationWork-related problems in multiple sclerosis: a literature review on its associates and determinants
Raggi, A., Covelli, V., Schiavolin, S., Scaratti, C., Leonardi, M., & Willems, M. (2015) · Disability and Rehabilitation · doi:10.3109/09638288.2015.1070295 · Cited by 145
Triccas, L. T., Burridge, J. H., Hughes, A., Pickering, R. M., Desikan, M., Rothwell, J. C., & Verheyden, G. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.04.067 · Cited by 143
Chronic cerebrovascular dysfunction after traumatic brain injury
Jullienne, A., Obenaus, A., Ichkova, A., Savona‐Baron, C., Pearce, W. J., & Badaut, J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23732 · Cited by 141
Hastrup, L. H., Jennum, P., Ibsen, R., Kjellberg, J., & Simonsen, E. H. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13094 · Cited by 149
Self-citationLueken, U., Zierhut, K. C., Hahn, T., Straube, B., Kircher, T., Reif, A., Richter, J., Hamm, A., Wittchen, H.-U., & Domschke, K. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.005 · Cited by 133
Millan, M. J., Goodwin, G. M., Meyer-Lindenberg, A., & Ove Ögren, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.016 · Cited by 132
Rooney, C., McKinley, M. C., & Woodside, J. V. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003388 · Cited by 130
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
Befort, K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00006 · Cited by 139
Behr, C., Goltzène, M.-A., Kosmalski, G., Hirsch, É., & Ryvlin, P. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2015.11.003 · Cited by 129
Disrupted Sleep: From Molecules to Cognition
Van Someren, E. J. W., Cirelli, C., Dijk, D.-J., Van Cauter, E., Schwartz, S., & Chee, M. W. L. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2592-15.2015 · Cited by 127
van Westrhenen, R., Aitchison, K. J., Ingelman‐Sundberg, M., & Jukić, M. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00094 · Cited by 138
Predictive analytics in mental health: applications, guidelines, challenges and perspectives
Hahn, T., Nierenberg, A. A., & Whitfield, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.201 · Cited by 131
Haeger, A., Costa, A. S., Schulz, J. B., & Reetz, K. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101933 · Cited by 142
Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon
Ma, M. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.010 · Cited by 125
Quercetin in brain diseases: Potential and limits
Dajas, F., Abin‐Carriquiry, J. A., Arredondo, F., Blasina, F., Echeverry, C., Martinez, M. M., Rivera, F., & Vaamonde, L. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.002 · Cited by 126
Birngruber, T., Raml, R., Gladdines, W., Gatschelhofer, C., Gander, E., Ghosh, A., Altendorfer‐Kroath, T., Gaillard, P. J., Pieber, T. R., & Sinner, F. M. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23994 · Cited by 122
Hamer, H. M., Dodel, R. C., Strzelczyk, A., Balzer‐Geldsetzer, M., Reese, J., Schöffski, O., Graf, W., Schwab, S., Knake, S., Oertel, W. H., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6509-3 · Cited by 122
Self-citationGender Differences in Dementia Spousal Caregiving
Pöysti, M. M., Laakkonen, M., Strandberg, T. E., Savikko, N. M., Tilvis, R. S., Eloniemi-Sulkava, U. R., & Pitkälä, K. H. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/162960 · Cited by 121
Sahakian, B. J., Brühl, A. B., Cook, J. L., Killikelly, C., Savulich, G., Piercy, T., Hafizi, S., Pérez, J., Fernández-Egea, E., Suckling, J., et al. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0214 · Cited by 121
A Microfluidic Ion Pump for In Vivo Drug Delivery
Uguz, I., Proctor, C. M., Curto, V. F., Pappa, A., Donahue, M. J., Ferro, M. P., Owens, R. M., Khodagholy, D., Inal, S., & Malliaras, G. G. (2017) · Advanced Materials · doi:10.1002/adma.201701217 · Cited by 119
Yuan, K., Zhao, L., Cheng, P., Yu, D., Zhao, L., Dong, T., Xing, L., Bi, Y., Yang, X., von Deneen, K. M., et al. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.02.010 · Cited by 118
Rubio‐Beltrán, E., Labastida‐Ramírez, A., Villalón, C. M., & MaassenVanDenBrink, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.005 · Cited by 118
D’Agata, F., Ruffinatti, F. A., Boschi, S., Stura, I., Rainero, I., Abollino, O., Cavalli, R., & Guiot, C. (2017) · Molecules · doi:10.3390/molecules23010009 · Cited by 120
Virtual Reality in Neurorehabilitation: An Umbrella Review of Meta-Analyses
Voinescu, A., Sui, J., & Fraser, D. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071478 · Cited by 121
Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties
Demeule, M., Beaudet, N., Régina, A., Besserer‐Offroy, É., Murza, A., Tétreault, P., Belleville, K., Ché, C., Larocque, A., Thiot, C., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70647 · Cited by 122
Mohammadi, E., Ghasemi, E., Azadnajafabad, S., Rezaei, N., Moghaddam, S. S., Meimand, S. E., Fattahi, N., Habibi, Z., Yarandi, K. K., Amirjamshidi, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247120 · Cited by 115
The European Academy of Neurology Brain Health Strategy: One brain, one life, one approach
Bassetti, C. L., Endres, M., Sander, A., Crean, M., Subramaniam, S., Carvalho, V., Liberto, G. D., Franco, O. H., Pijnenburg, Y. A. L., Leonardi, M., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15391 · Cited by 114
The cost and impact of compulsivity: A research perspective
Hollander, E., Doernberg, E. A., Shavitt, R. G., Waterman, R. J., Soreni, N., Veltman, D. J., Sahakian, B. J., & Fineberg, N. A. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.02.006 · Cited by 120
Brain–Immune Interactions and Neuroinflammation After Traumatic Brain Injury
Dinet, V., Petry, K. G., & Badaut, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01178 · Cited by 119
Internet and mobile interventions for depression: Opportunities and challenges: Cuijpers et al .
Cuijpers, P., Kleiboer, A., Karyotaki, E., & Riper, H. (2017) · Depression and Anxiety · doi:10.1002/da.22641 · Cited by 112
Traumatic Brain Injury in the Netherlands: Incidence, Costs and Disability-Adjusted Life Years
Scholten, A. C., Haagsma, J. A., Panneman, M. J. M., van Beeck, E. F., & Polinder, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110905 · Cited by 112
Animals, anxiety, and anxiety disorders: How to measure anxiety in rodents and why
Harro, J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.016 · Cited by 122
Beecham, J. K. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12216 · Cited by 127
Executive Functions in Insomnia Disorder: A Systematic Review and Exploratory Meta-Analysis
Ballesio, A., Aquino, M. R. J., Kyle, S. D., Ferlazzo, F., & Lombardo, C. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00101 · Cited by 125
Fang, Y., Gao, S., Wang, X., Cao, Y., Lü, J., Chen, S., Lenahan, C., Zhang, J. H., Shao, A., & Zhang, J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00068 · Cited by 114
Psychische Auffälligkeiten von Kindern und Jugendlichen in Deutschland
Klasen, F., Meyrose, A., Otto, C., Reiss, F., & Ravens‐Sieberer, U. (2017) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-017-0270-8 · Cited by 110
Psychedelic Microdosing: Prevalence and Subjective Effects
Cameron, L. P., Nazarian, A., & Olson, D. E. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1718250 · Cited by 110
Wrestling with stress: Roles of protein SUMOylation and deSUMOylation in cell stress response
Guo, C., & Henley, J. M. (2014) · IUBMB Life · doi:10.1002/iub.1244 · Cited by 109
The governmentalization of living: calculating global health
Wahlberg, A., & Rose, N. (2015) · Economy and Society · doi:10.1080/03085147.2014.983830 · Cited by 115
Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors
Schmitt, A., Falkai, P., & Papiol, S. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02567-5 · Cited by 125
Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review
von der Warth, R., Dams, J., Grochtdreis, T., & König, H. (2020) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1753940 · Cited by 106
Anxiety disorders and PTSD in Palestine: a literature review
Marie, M., SaadAdeen, S., & Battat, M. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02911-7 · Cited by 105
Factors influencing the success of exposure therapy for specific phobia: a systematic review
Böhnlein, J., Altegoer, L., Muck, N. K., Roesmann, K., Redlich, R., Dannlowski, U., & Leehr, E. J. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.009 · Cited by 98
Pittig, A., Heinig, I., Goerigk, S. A., Richter, J., Hollandt, M., Lueken, U., Pauli, P., Deckert, J., Kircher, T. T. J., Straube, B., et al. (2022) · Clinical Psychological Science · doi:10.1177/21677026221101379 · Cited by 105
Malchow, B., Keller, K., Hasan, A., Dörfler, S., Schneider-Axmann, T., Hillmer-Vogel, U., Honer, W. G., Schulze, T. G., Niklas, A., Wobrock, T., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv020 · Cited by 112
Squillaro, T., Cimini, A., Peluso, G., Giordano, A., & Melone, M. A. B. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.05.016 · Cited by 104
Jacobi, F., Mack, S., Gerschler, A., Scholl, L., Höfler, M., Siegert, J., Bürkner, A., Preiss, S., Spitzer, K., Busch, M. A., et al. (2013) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1387 · Cited by 103
Self-citationCost of Disorders of the Brain in Spain
Parés‐Badell, O., Barbaglia, G., Jerinic, P., Gustavsson, A., Salvador‐Carulla, L., & Alonso, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105471 · Cited by 98
Self-citationRoca, P., Attyé, A., Colas, L., Tucholka, A., Rubini, P., Cackowski, S., Ding, J., Budzik, J., Renard, F., Doyle, S., et al. (2020) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2020.05.009 · Cited by 100
Bulteau, S., Laurin, A., Péré, M., Fayet, G., Thomas-Ollivier, V., Deschamps, T., Auffray-Calvier, E., Bukowski, N., Vanelle, J., Sebille, V., et al. (2022) · Brain stimulation · doi:10.1016/j.brs.2022.05.011 · Cited by 101
Specificity and overlap of attention and memory biases in depression
Marchetti, I., Everaert, J., Dainer‐Best, J., Loeys, T., Beevers, C. G., & Koster, E. H. W. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.037 · Cited by 106
Ochoa, S., López-Carrilero, R., Barrigón, M. L., Pousa, E., Barajas, A., Lorente-Rovira, E., González-Higueras, F., Grasa, E., Ruiz-Delgado, I., Cid, J., et al. (2017) · Psychological Medicine · doi:10.1017/s0033291716003421 · Cited by 97
Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving
Prusa, A., Kasper, D. C., Sawers, L., Walter, E., Hayde, M., & Stillwaggon, E. M. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005648 · Cited by 98
Saraulli, D., Costanzi, M., Mastrorilli, V., & Vecchioli, S. F. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160412150223 · Cited by 104
Calzaferri, F., Ruiz‐Ruiz, C., de Diego, A. M. G., de Pascual, R., Méndez‐López, I., Cano‐Abad, M. F., Maneu, V., Ríos, C. D. L., Gandía, L., & de Diego, A. M. G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21710 · Cited by 101
Medial prefrontal cortex neuronal circuits in fear behavior
Courtin, J., Bienvenu, T., Einarsson, E. Ö., & Herry, C. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.001 · Cited by 108
Advances in the Treatment of Neurodegenerative Disorders Employing Nanoparticles
Spuch, C., Ortolano, S., & Navarro, C. (2012) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221112799219125 · Cited by 98
Medial prefrontal cortex stimulation accelerates therapy response of exposure therapy in acrophobia
Herrmann, M. J., Katzorke, A., Busch, Y., Gromer, D., Polak, T. T., Pauli, P., & Deckert, J. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.11.007 · Cited by 95
Relationship between functional disability and costs one and two years post stroke
Lekander, I., Willers, C., von Euler, M., Lilja, M., Sunnerhagen, K. S., Pessah-Rasmussen, H., & Borgström, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174861 · Cited by 95
Developments in the field of antidepressants, where do we go now?
Artigas, F. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.04.013 · Cited by 100
Irving, J., Patel, R., Oliver, D., Colling, C., Pritchard, M., Broadbent, M., Baldwin, H., Stahl, D., Stewart, R., & Fusar-Poli, P. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa126 · Cited by 92
Schmitt, A., Maurus, I., Rossner, M. J., Röh, A., Lembeck, M., von Wilmsdorff, M., Takahashi, S., Rauchmann, B., Keeser, D., Hasan, A., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00690 · Cited by 112
Silote, G. P., Sartim, A. G., Sales, A. J., Eskelund, A., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2019) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2019.04.006 · Cited by 98
Artigas, F., Bortolozzi, A. A., & Celada, P. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.10.032 · Cited by 96
The Economic Burden of Alcohol Dependence in Europe
Laramée, P., Kusel, J., Leonard, S. A., Aubin, H., François, C., & Daeppen, J. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt004 · Cited by 91
Negro, A., Sciattella, P., Rossi, D., Guglielmetti, M., Martelletti, P., & Mennini, F. S. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1068-y · Cited by 89
Clinical classification in mental health at the cross-roads: which direction next?
Hickie, I. B., Scott, J. L., Hermens, D. F., Scott, E. M., Naismith, S. L., Guastella, A. J., Glozier, N., & McGorry, P. D. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-125 · Cited by 88
Personalized medicine approaches in epilepsy
Walker, L. E., Mirza, N., Yip, V. L. M., Marson, A. G., & Pirmohamed, M. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12322 · Cited by 89
Metadata
- Authors
- Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., Gannon, B., Jones, D. H., Jennum, P., Jordanova, A., Jönsson, L., Karampampa, K., Knapp, M., Kobelt, G., Kurth, T., Lieb, R., Linde, M., Ljungcrantz, C., Maercker, A., Melin, B., Moscarelli, M., Musayev, A., Norwood, F., Preisig, M., Pugliatti, M., Rehm, J., Salvador-Carulla, L., Schlehofer, B., Simon, R., Steinhausen, H.-C., Stovner, L. J., Vallat, J.-M., den Bergh, P. V., van Os, J., Vos, P., Xu, W., Wittchen, H.-U., Jönsson, B., & Olesen, J.
- Affiliations
- Karlstad University (SE)
- Technische Universität Dresden (DE)
- Karolinska University Hospital (SE)
- Municipal Institute for Medical Research (ES)
- Mario Negri Institute for Pharmacological Research (IT)
- Philipps University of Marburg (DE)
- University of Florence (IT)
- Karolinska Institutet (SE)
- University of Leeds (GB)
- Glostrup Hospital (DK)
- University of Antwerp (BE)
- King's College London (GB)
- Lund University (SE)
- Harvard University (US)
- University of Basel (CH)
- Norwegian University of Science and Technology (NO)
- Umeå University (SE)
- King's College Hospital (GB)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Sassari (IT)
- German Cancer Research Center (DE)
- European Monitoring Centre for Drugs and Drug Addiction (PT)
- Aalborg University Hospital (DK)
- Centre Hospitalier Universitaire de Limoges (FR)
- Radboud University Nijmegen (NL)
- Stockholm School of Economics (SE)
- Corresponding author
- Olesen, Jes
- ORCID
- Gustavsson, Anders
- Svensson, Mikael
- Jacobi, Frank
- Alonso, Jordi
- Beghi, Ettore
- Dodel, Richard
- Ekman, Mattias
- Fratiglioni, Laura
- Gannon, Brenda
- Jennum, Poul
- Jordanova, Albena
- Jönsson, Linus
- Karampampa, Korinna
- Knapp, Martin
- Kobelt, Gisela
- Kurth, Tobias
- Lieb, Roselind
- Linde, Mattias
- Ljungcrantz, Christina
- Melin, Beatrice
- Moscarelli, Massimo
- Preisig, Martin
- Pugliatti, Maura
- Steinhausen, Hans-Christoph
- Stovner, Lars Jacob
- Vallat, Jean-Michel
- Xu, Weili
- Olesen, Jes
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 21
- Issue
- 10
- Pages
- 718-779
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2131786905
- Cited by
- 1,723
- References
- 427
- Citations by year
- 2026: 42 · 2025: 64 · 2024: 70 · 2023: 88 · 2022: 100 · 2021: 133 · 2020: 123 · 2019: 120 · 2018: 233 · 2017: 130 · 2016: 141 · 2015: 142 · 2014: 124 · 2013: 118 · 2012: 81
- FWCI
- 145.35
- Type
- journal article
- Language
- en
- Open access
- green
- tud.qucosa.de
- Licence
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- IRIS (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- mental illness, neurological disorders, economic burden, prevalence, direct and indirect costs, cost model, Europe, brain tumors, dementia, epilepsy, multiple sclerosis, stroke, traumatic brain injury, Parkinson's disease, migraine, developmental disorders, neuromuscular disorders, sleep disorders, somatoform disorders, cost per person
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Mental Disorders, Brain Diseases, Child, Child, Preschool, Europe, Health Expenditures, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Public Health, Prevalence, Health Care Costs, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
